GSK announces independent Consumer Healthcare company is …
Feb 22, 2022 · GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon.
Update - GSK Consumer Healthcare
Jan 15, 2022 · Global leader in Consumer Healthcare. The Consumer Healthcare business has been transformed since 2014 through the successful integrations of GSK’s business with the Novartis consumer health portfolio in 2015 and the Pfizer portfolio in 2019.
GSK Completes Spin Off Of Its Consumer Healthcare Business - Yahoo Finance
Jul 18, 2022 · GSK plc (NYSE: GSK) has completed the demerger of the Consumer Healthcare business to form the Haleon Group. Reuters reported that shares in Haleon started trading at 330 pence on Monday...
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By ... - Forbes
Jul 15, 2021 · On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed company. The...
Consumer Healthcare Demerger - GSK
On Monday 18 July 2022, GSK plc (“GSK” or the “Company”) separated its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company. The separation was effected by way of a demerger (the “Demerger”) of approximately 80% of GSK’s 68% holding in the Consumer Healthcare business to ...
Pfizer and GlaxoSmithKline Announce Joint Venture to Create a …
Pfizer Inc. (NYSE: PFE) and GlaxoSmithKline plc (NYSE:GSK) today announced they have entered into an agreement to create a premier global consumer healthcare company with robust iconic brands.
GSK announces independent Consumer Healthcare company is …
Haleon will be a new world-leader in consumer health with an exceptional portfolio of category-leading brands, including Sensodyne, Voltaren, Panadol and Centrum. Business is on track to demerge and list as a new company in mid-2022.
GSK spins off consumer health business worth up to $57 billion
Jan 15, 2022 · British drugmaker GSK will spin off its consumer health business Haleon worth up to an estimated 48 billion pounds ($57 billion) on Monday in the biggest listing in Europe in over a decade.
Update - GSK Consumer Healthcare – Company Announcement
Jan 15, 2022 · GlaxoSmithKline (GSK) plc today confirms that it has received three unsolicited, conditional and non-binding proposals from Unilever plc to acquire the GSK Consumer Healthcare business. The...
Consumer Healthcare Joint Venture - GSK
The Joint Venture is a category leader in Pain Relief, Respiratory, Vitamin and Mineral Supplements, Digestive Health, OTC Skin Health and Therapeutic Oral Health. Through the combination of GSK and Pfizer’s consumer healthcare businesses we are creating substantial further value for shareholders.